abstract |
The present invention regulates the expression or activity of PGC-1β by regulating lipid-related diseases and disorders (eg hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, cardiovascular disease, obesity and type II diabetes ) As well as methods for modulating lipid biosynthesis, lipid transport, plasma triglyceride levels and / or plasma cholesterol levels. Also described are methods for identifying compounds that can treat or prevent lipid-related diseases or disorders. |